МЕСТО ЭПИНЕФРИНА В ПРОФИЛАКТИКЕ ГЕМАТОМ ЛОЖА ЭЛЕКТРОКАРДИОСТИМУЛЯТОРА

С целью оценки эффективности и безопасности применения эпинефрина при местной анестезии во время имплантации электрокардиостимуляторов для профилактики формирования гематом ложа обследованы и прооперированы 133 пациента.

электрокардиостимулятор, гематома ложа, местная анестезия, лидокаин, эпинефрин, антиагреганты, антикоагулянты, дренаж

1. Ohlow, M.A. Pocket related complications in 163 patients receiving anticoagulation or dual antiplatelet therapy: D-Stat hemostat versus standard of care / M.A. Ohlow, B. Lauer, M. Schreiber // Int J Cardiol - 2012. - 159. - P. 177-180.

2. Cardiac device infections is associated with pocket hematoma and diabetes mellitus: The role of the cardiovascular nurse / F.V. Martin-Casanas [et al.] // International Journal of Cardiology. - 2014. - 171. - e5-e7.

3. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems / R.K. Aggarwal [et al.] // Br Heart J - 1995. - 73. - P. 571-575.

4. Двухлетний опыт эндокардиальной стимуляции сердца / В.В. Макеев [и др.] // Вестник аритмологии. - 1999. - №14. - С. 76.

5. Pocket hematoma after pacemaker or implantable cardioverter defibrillator surgery: influence of patient morbidity, operation strategy, and perioperative antiplatelet/ anticoagulation therapy / U.K. Wiegand [et al.] // Chest. - 2004. - 126. - P. 1177-1186.

6. Association between hospital procedure volume and early complications after pacemaker implantation: results from a large, unselected, contemporary cohort of the German nationwide obligatory external quality assurance programme / B.Nowak [et al.] // Europace. - 2015. - 17(5). - P. 787-793.

7. Anticoagulation and antiplatelet therapy in implantation of electrophysiological devices / Panagiotis Korantzopoulos [et al.] // Europace - 2011. - 13. - P. 1669-1680.

8. Birnie, D.H. Wells Pacemaker or Defibrillator surgery without interruption of anticoagulation / D. H. Birnie, J. S. Healey, G. A. Wells // The New England Journal of Medicine. - 2013 - 368. - P. 2084-2092.

9. Thrombocytopenia, dual antiplatelet therapy, and heparin bridging strategy increase pocket hematoma complications in patients undergoing cardiac rhythm device implantation / H.C. Chen [et al.] // - 2013. - №29(9). - P. 1110-1117.

10. Modern Pacemakers - Present and Future. Edited by Mithilesh Kumar Das, 2011. - Chapter 16. - P. 308-309.

11. Волков, Д.Е. Хирургические аспекты трансвенозной имплантации электрокардиостимуляторов: наш подход к снижению риска гнойно-воспалительных осложнений / Д.Е. Волков // Харьковская хирургическая школа.с- 2013. - 3(60). - С. 115-118.

12. Risk of Hematoma Complications After Device Implant in the Clopidogrel Era / I.B. Kutinsky [et al.] // Circ Arrhythm Electrophysiol. - 2010. -3. - P. 312-318.

13. Имплантация электрокардиостимулятора. Медицинская технология. Новосибирск, 2008. - 29 С.

14. Prevention of pocket related complications with fibrin sealant in patients undergoing pacemaker implantation who are receiving anticoagulant treatment / D. J. Milic [et al.] // Europace. - 2005. - 7. - P. 374-379.

15. Pocket Hematoma: A Call for Definition / D.E. Sensi [et al.] // Pacing Clin Electrophysiol. - 2015. - 38(8). - P. 909-913.

16. Niederhuber, J.E. Totally Implantable Venous Access Devices. Management in Mid- and Long-term Clinical Setting. Part IV / J. E. Niederhuber. - Milan: Springer, 2012. - P. 153-156.

17. Infection after pacemaker implantation: infection rates and risk factors associated with infection in a population-based cohort study of 46299 consecutive patients / J.B. Johansen [et al.] // Eur Heart J. - 2011. - 32(8). P. 991-998.

18. Hematoma complicating permanent pacemaker implantation: The role of periprocedural antiplatelet or anticoagulant therapy / K.S. Özcan [et al.] // Journal of Cardiology. - 2013. - 62. - P. 127-130.

19. Polyzos, K.A. Risk factors for cardiac implantable electronic device infection: a systematic review and metaanalysis / K.A. Polyzos, A.A. Konstantelias, M.E. Falagas // Europace. - 201. -17(5). - P. 767-777.